title: Could Pharmacologic Lung Deflation Modify Cardiac Structural and Functional Alterations?
authors.affiliation: 1 Erciyes University School of Medicine Kayseri, Turkey.
authors.forename: Goktug
authors.initials: G
authors.lastname: Savas
authors.affiliation: 1 Erciyes University School of Medicine Kayseri, Turkey.
authors.forename: Nihat
authors.initials: N
authors.lastname: Kalay
authors.affiliation: 1 Erciyes University School of Medicine Kayseri, Turkey.
authors.forename: Inci
authors.initials: I
authors.lastname: Gulmez
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage*; D000730:Androstadienes / Q000008:administration & dosage*; D001592:Benzyl Alcohols / Q000008:administration & dosage*; D002722:Chlorobenzenes / Q000008:administration & dosage*; D005260:Female; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008168:Lung / Q000503:physiopathology*; D008297:Male; D009206:Myocardium / Q000473:pathology*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D000730:Androstadienes; D001592:Benzyl Alcohols; D002722:Chlorobenzenes